Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update
Aethlon Medical, Inc. (AEMD)
NASDAQ:AMEX Investor Relations:
ir.aethlonmedical.com
Company Research
Source: PR Newswire
Clinical and research programs continue to advance, supported by year-to-date cost efficienciesConference Call Today at 4:30 p.m. ETSAN DIEGO, Feb. 12, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (the Company or Aethlon) (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today reported financial results for its fiscal third quarter ended December 31, 2025, and provided an update on recent developments. Key HighlightsMaintained Nasdaq Listing: Continued compliance with Nasdaq listing requirements, with all prior compliance matters remaining resolved. Clinical Progress: Cohort 2 of the Australian oncology trial is actively progressing, reflecting continued clinical execution.Scientific Advancement: Continued advancement of the Company's preclinical extracellular vesicle (EV) research platform, including Long COVID data published on bioRxiv and submitted for peer review, supporting the Hemopurifier's poten
Show less
Read more
Impact Snapshot
Event Time:
AEMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AEMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AEMD alerts
High impacting Aethlon Medical, Inc. news events
Weekly update
A roundup of the hottest topics
AEMD
News
- Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026 [Yahoo! Finance]Yahoo! Finance
- Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026PR Newswire
- Aethlon Medical Inc (AEMD) Q3 2026 Earnings Call Highlights: Progress in Oncology Trials and ... [Yahoo! Finance]Yahoo! Finance
- Aethlon Medical signals faster clinical trial enrollment amid Hemopurifier advancements [Seeking Alpha]Seeking Alpha
- Aethlon Medical, Inc. (AEMD) Q3 2026 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
AEMD
Earnings
- 2/12/26 - Miss
AEMD
Sec Filings
- 2/23/26 - Form 8-K
- 2/17/26 - Form SCHEDULE
- 2/17/26 - Form SCHEDULE
- AEMD's page on the SEC website